ER AND PR
1 Test Included
Estrogen receptor (ER), progesterone receptor (PR), and c-ERBB2 (HER2/neu) are therapeutically and prognostically important markers in the management of breast carcinoma. They are not always analyzed in distant metastatic and locally recurrent breast cancers.
Provide a copy of the Histopathology report, Site of biopsy and Clinical history.